Logo

Nabsys

Nabsys to Take Another Shot at Commercializing Electronic Genome Mapping Technology Next Year
Premium

The Providence, Rhode Island-based firm plans to release its electronic genome mapping technology for human genome applications.

Nabsys Raises Additional $13M From Hitachi High-Technologies

Providence, Rhode Island-based Nabsys said the additional funding was a result of a technical milestone for its high-definition genome mapping platform.

Nabsys Secures up to $38M in Equity Financing From Hitachi High-Tech

The electronic genome mapping company said it will initially receive $25 million and can get an additional $13 million upon achieving certain milestones.

Genome In a Bottle Consortium Releases Structural Variant Calling Benchmark Data
Premium

The public-private partnership has published a paper on a list of indels larger than 50 bp that is already being used to develop new methods.

Nabsys Raises $21M in Round Led by Hitachi High-Technologies

The company plans to use the funding to finish developing and commercially launch its HD-Mapping whole-genome electronic mapping platform.

May 24, 2017

Nabsys Aims to Commercialize Genome Mapping Instrument Next Year
Premium

Oct 12, 2016

Nabsys Generates First Electronic Long-Range Human Genome Maps to Test Structural Variant Calling
Premium

Mar 31, 2016

Following Financial Restructuring, Nabsys Resurfaces With Much of Original Leadership Team

Sep 14, 2015

Report: Nabsys Shuts Down

Jan 20, 2015

Nabsys Using DNA Mapping Tech in 'Collaborative Mode'; Eyes Cancer Structural Variant Panels
Premium

Jan 12, 2015

Nabsys, Ariana Pharmaceuticals Collaborate to ID Structural Variants Linked to Cancer

Nov 11, 2014

IP Roundup: NabSys, IMDx, Affymetrix, and Illumina Win US Patents
Premium

Nov 4, 2014

With New Management, Nabsys Shifts Focus to Cancer Structural Variation Analysis
Premium

Oct 29, 2014

People in the News: Jeffrey Leiden, Anthony Shuber
Premium

Oct 28, 2014

Paired Ends: Anthony Shuber, Greg Lucier, Craig Tuttle
Premium

Oct 14, 2014

IP Roundup: Affymetrix, Nabsys, Ohio State U, Fujirebio Win US Patents
Premium

Feb 25, 2014

Nabsys to Commercialize Electronic DNA Mapping Platform in 2014; Shows Data at AGBT
Premium

Mar 13, 2013

Nabsys Raises $20M in Private Financing Round

Jan 15, 2013

Nabsys to Launch First Version of Sequencing System this Year for Genome Mapping Applications
Premium

Jan 17, 2012

Nabsys Develops 'Positional Sequencing' Tech for Assembly, Whole-Genome Mapping, Targeted Sequencing
Premium

Jan 10, 2012

Nabsys Prepares to Commercialize Nanodetector 'Positional Sequencing' Tech
Premium

Jan 10, 2012

Paired Ends: Marc Stapley, Stan Rose, Michael Hunkapiller, Jeffrey Sklar, Martin Tolar
Premium

Jan 3, 2012

Desktop Sequencers Take Center Stage in 2011 as Platform Providers Face Tough Times
Premium

Sep 20, 2011

Nabsys Raises $10M for Development of its Semiconductor-Based Sequencing System
Premium

Sep 14, 2011

Sequencing Technology Firm Nabsys Raises $10M in Series C Round

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.